GD researchers provide new treatment for patients with locally advanced colon cancer
A study conducted by professors and physician from the Sixth Affiliated Hospital of Sun Yat-sen University, as well as other researchers, revealed that neoadjuvant chemotherapy (NAC) with oxaliplatin and fluoropyrimidine was safe, resulted in substantial pathologic downstaging, and appears to be a viable therapeutic option for locally advanced colon cancer. The results were recently published online in the Journal of Clinical Oncology (JCO).
2024-04-09 16:36:07
